• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evidence for an androgen-binding component in the cytosol of the human term placenta.

作者信息

Stanley R L, Milwidsky A, Besch P K, Milwidsy A

出版信息

Am J Obstet Gynecol. 1980 Apr 15;136(8):1003-5. doi: 10.1016/0002-9378(80)90626-2.

DOI:10.1016/0002-9378(80)90626-2
PMID:6966131
Abstract

The present communication describes a specific, high-affinity (Kd = 1.9 +/- 0.21 x 10(-9)M; n = 3) binding component for dihydrotestosterone present in the high-speed, hormone-stripped cytosol fraction of the human term placenta. In order to delineate the nature of this substance, the synthetic steroids R1881 (progesterone and androgen receptor specific) and R5020 (progesterone receptor specific) were employed. Minimal binding of H3-R5020 was observed; however, H3-R1881 was found to bind with a Kd = 0.6 +/- 0.18 x 10(-9)M (n = 3). The relative displacing ability of R5020 for H3-R1881 was only 1.3%, substantiating the presence of an androgen binder and negating the presence of a significant level of a progesterone-binding component. Evidence that the binder is of placental origin and does not result from blood contamination includes no significant binding of H3-R1881 to pregnancy serum, binder thermolability at 45 degrees C, and precipitation of the binder by ammonium sulfate at 30% saturation. Speculations as to the receptor or receptor-like nature of the binder are presented.

摘要

相似文献

1
Evidence for an androgen-binding component in the cytosol of the human term placenta.
Am J Obstet Gynecol. 1980 Apr 15;136(8):1003-5. doi: 10.1016/0002-9378(80)90626-2.
2
Evidence for an androgen binding component in human placental cytosol.
J Steroid Biochem. 1982 Feb;16(2):311-5. doi: 10.1016/0022-4731(82)90182-0.
3
Human placenta contains a high affinity R1881 binding site that is not the androgen receptor.
J Steroid Biochem. 1988 May;29(5):497-503. doi: 10.1016/0022-4731(88)90184-7.
4
Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
J Steroid Biochem. 1986 Sep;25(3):367-74. doi: 10.1016/0022-4731(86)90249-9.
5
Binding of [3H]-methyltrienolone (R1881) by human breast cancers.
Eur J Cancer Clin Oncol. 1983 Oct;19(10):1473-8. doi: 10.1016/0277-5379(93)90018-z.
6
Androgen receptor in human placental villi.
J Biochem. 1981 Jan;89(1):153-60. doi: 10.1093/oxfordjournals.jbchem.a133176.
7
Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the rat.
J Steroid Biochem. 1985 Jan;22(1):57-62. doi: 10.1016/0022-4731(85)90141-4.
8
Evidence for an androgen receptor in the human placenta.
Am J Obstet Gynecol. 1981 May 1;140(1):8-13. doi: 10.1016/0002-9378(81)90250-7.
9
Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.R5020和RU486与小牛子宫孕酮受体结合的特性研究
Biochemistry. 1988 May 17;27(10):3618-23. doi: 10.1021/bi00410a014.
10
Characterization of steroid receptors in human prostate using mibolerone.
Prostate. 1986;8(3):241-53. doi: 10.1002/pros.2990080305.